Benazepril Hydrochloride And Hydrochlorothiazide Tablet, Film Coated
NDC Package 68462-577-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Benazepril Hydrochloride And Hydrochlorothiazide tablets are indicated for the treatment of hypertension.This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION). This formulation utilizes a tablet, film coated delivery system. Marketed by Glenmark Pharmaceuticals Inc., Usa, this product is identified by NDC 68462-577 and is authorized under FDA application ANDA076631.

Identification & Billing

NDC Package Code
68462-577-01
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
68462-577
11-Digit Billing Format
68462057701
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 898362 - benazepril HCl 10 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
  • RxCUI: 898362 - benazepril hydrochloride 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet
  • RxCUI: 898362 - benazepril hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet
  • RxCUI: 898362 - BZP hydrochloride 10 MG / HCTZ 12.5 MG Oral Tablet
  • RxCUI: 898367 - benazepril HCl 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Benazepril Hydrochloride And Hydrochlorothiazide
Non-Proprietary Name
Benazepril Hydrochloride And Hydrochlorothiazide
Substance Name
Benazepril Hydrochloride; Hydrochlorothiazide
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Benazepril hydrochloride and hydrochlorothiazide tablets are indicated for the treatment of hypertension.This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION).

Regulatory & Marketing

Labeler Name
Glenmark Pharmaceuticals Inc., Usa
Product Type
Human Prescription Drug
FDA Application #
ANDA076631
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-04-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68462-577-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Benazepril Hydrochloride And Hydrochlorothiazide, a human prescription drug labeled by Glenmark Pharmaceuticals Inc., Usa. This tablet, film coated is formulated for oral use and contains benazepril hydrochloride; hydrochlorothiazide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Pharmaceuticals Inc., Usa on April 04, 2014. The current certification is valid through December 31, 2026.

How is this Glenmark Pharmaceuticals Inc., Usa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68462057701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68462-577-01
11-Digit CMS (5-4-2)
68462-0577-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.